Skip to main content
Clinical Trials/ITMCTR2100004957
ITMCTR2100004957
Recruiting
Phase 1

Clinical study on prevention of new onset atrial fibrillation after pneumonectomy by perioperative Electroacupuncture

Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine0 sitesTBD
Conditionslung cancer

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
lung cancer
Sponsor
Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. No other serious complications occurred in the patients with lung tumor who underwent thoracoscopic lobectomy or pneumonectomy;
  • 2\. Aged 60 to 85 years, ASA I\-III, no gender restriction;
  • 3\. Patients who have completed auxiliary examination and have no immune system diseases;
  • 4\. Those who understand and agree to participate in the study and sign the informed consent.

Exclusion Criteria

  • 1\. Arrhythmia before operation;
  • 2\. The patients with thyroid dysfunction before operation;
  • 3\. Taken within 1 month before operation ß\- Receptor blockers and digitalis;
  • 4\. History of cardiothoracic surgery;
  • 5\. The patients with nerve injury of upper limb or lower extremity;
  • 6\. Patients with skin infection in the acupoints;
  • 7\. Patients with acupuncture and moxibustion treatment history;
  • 8\. Patients who cannot cooperate with the completion of the research plan, including language difficulties, infectious diseases and other medical history;
  • 9\. Participated in other clinical trials in the past four weeks.

Outcomes

Primary Outcomes

Not specified

Similar Trials